Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Sionna Therapeutics, Inc.NASDAQ: SION
Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) falls 12.6% from a year ago
Property, plant & equipment (net) stood at $8.75M at the end of Q1 FY2026, down 12.6% from a year earlier and down 4.4% from the prior quarter. Over 3 fiscal years it compounded at +52.6% a year.
Context
- Property, plant & equipment (net) amounted to 2.9% of total assets at the end of Q1 FY2026, up 0.2 pp from a year earlier.
- Property, plant & equipment (net) increased in 1 of the last 3 fiscal years.
What to watch
Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -12.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 9.15M USD
- Year-over-year change
- -11.1%
- 3-year CAGR
- +52.6%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 9.15M | -11.1% |
| FY2024 | 2024-12-31 | 10.3M | -12.2% |
| FY2023 | 2023-12-31 | 11.73M | +355.8% |
| FY2022 | 2022-12-31 | 2.57M | — |
Property, Plant & Equipment (Net) vs competitors
How SION compares with its peers on the latest reported figures
- SION's Mar 2026 property, plant & equipment (net) of $8.75M is the 9th highest of the 11 companies compared; the peer median is $21.17M.
- Its year-over-year change of -12.6% is the 8th highest of 11, against a peer median of -3.5%.
- Property, plant & equipment (net) amounts to 2.9% of total assets for SION, versus a peer median of 4.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $410.05M | -4.1% | +25.4% | 27.3% | |
| Sep 2026 | $63.5M | +95.6% | — | 5.4% | |
| Mar 2026 | $26.98M | -2.9% | +41.7% | 6.9% | |
| Mar 2026 | $23.97M | -16.8% | -15.2% | 5.7% | |
| Mar 2026 | $21.42M | -10.1% | -8.8% | 2.1% | |
| Sep 2026 | $20.92M | +177.2% | +0.1% | 2.9% | |
| Sep 2026 | $20.55M | +39.9% | +163.3% | 4.1% | |
| Jun 2026 | $15.09M | -71.4% | -32.7% | 4.1% | |
| Mar 2026 | $8.75M | -12.6% | +52.6% | 2.9% | |
| Mar 2026 | $6.44M | +20.6% | -12.8% | 1.3% | |
| Jun 2026 | $1.69M | -53.4% | -28.3% | 0.3% | |
| Peer median (excluding SION) | $21.17M | -3.5% | -8.8% | 4.1% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.